These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


315 related items for PubMed ID: 3788764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction.
    Iesaka Y, Aonuma K, Nitta J, Tokunaga T, Fujiwara H, Hiraoka M.
    Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic efficacy and hemodynamic effects of cibenzoline in patients with nonsustained ventricular tachycardia and left ventricular dysfunction.
    Seals AA, Haider R, Leon C, Francis M, Young JB, Roberts R, Pratt CM.
    Circulation; 1987 Apr; 75(4):800-8. PubMed ID: 3549044
    [Abstract] [Full Text] [Related]

  • 6. [Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia].
    Hoffmann E, Bach P, Haberl R, Mattke S, Steinbeck G.
    Z Kardiol; 1992 Jul; 81(7):378-84. PubMed ID: 1509795
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spontaneous ventricular tachycardia associated with isolated right ventricular infarction, one day after right coronary artery occlusion in the dog: studies on the site of origin and mechanism.
    Sugi K, Karagueuzian HS, Fishbein MC, McCullen A, Sato Y, Ganz W, Mandel WJ, Peter T.
    Am Heart J; 1985 Feb; 109(2):232-44. PubMed ID: 3966341
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS.
    Am J Cardiol; 1984 Aug 13; 54(4):37B-42B. PubMed ID: 6465045
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
    Avitall B, Hare J, Zander G, Bockoff C, Tchou P, Jazayeri M, Akhtar M.
    Circulation; 1992 Apr 13; 85(4):1582-93. PubMed ID: 1555296
    [Abstract] [Full Text] [Related]

  • 14. Arrhythmogenic effects of antiarrhythmic drugs in patients with an old myocardial infarction and asymptomatic ventricular ectopic activity as studied by programmed electrical stimulation.
    Farré J, Grande A, Albo PS, Martí F, Martínez-Romero P, Alfonso F, Rábago P.
    Eur Heart J; 1987 Mar 13; 8 Suppl A():113-9. PubMed ID: 2438133
    [Abstract] [Full Text] [Related]

  • 15. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG, Martins JB, Wendt DJ, Constantin L, Hopson R, McCue ML.
    Am J Cardiol; 1988 May 01; 61(13):1012-7. PubMed ID: 3129926
    [Abstract] [Full Text] [Related]

  • 16. Discordant results of programmed ventricular stimulation at different right ventricular sites in patients with and without spontaneous sustained ventricular tachycardia: a prospective study of 56 patients.
    Doherty JU, Kienzle MG, Buxton AE, Marchlinski FE, Waxman HL, Josephson ME.
    Am J Cardiol; 1984 Aug 01; 54(3):336-42. PubMed ID: 6465014
    [Abstract] [Full Text] [Related]

  • 17. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec 01; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 18. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST, Saksena S.
    Am J Cardiol; 1986 Apr 15; 57(11):941-6. PubMed ID: 3515898
    [Abstract] [Full Text] [Related]

  • 19. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):49B-54B. PubMed ID: 6465047
    [Abstract] [Full Text] [Related]

  • 20. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
    Kirchhof PF, Fabritz CL, Franz MR.
    Circulation; 1998 Jun 30; 97(25):2567-74. PubMed ID: 9657478
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.